leprosy elimination

Novartis Foundation and Partners Call for a Global Effort to Make Leprosy History

In two articles in the Lancet Infectious Diseases, the Novartis Foundation and its partners review the historic and future innovations and game-changing strategies in leprosy elimination, calling for a global effort to make leprosy history.
Press Release

July 10, 2017 /3BL Media/  - On July 7th, 2017 the Novartis Foundation and its partners published two articles that call for a global effort to make leprosy history. The reviews have been published in the Lancet Infectious Diseases, a leading journal in infectious diseases.[i]

Novartis Foundation Commemorates World Leprosy Day with its Continued Efforts to go the Last Mile Toward Elimination

2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease
Summary: 
  • 2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease

  • New strategy from the Novartis Foundation to accelerate elimination is focused on interrupting transmission of the disease

  • Last year Novartis renewed its commitment with the WHO to donate multidrug therapy to treat leprosy through the year 2020

  • More than 200,000 people are diagnosed with leprosy every year; approximately 10% of those are children, indicating continued spread of the disease
Press Release
  • 2016 marks 30 years of commitment by the Novartis Foundation to support people affected by leprosy and to end this ancient disease

  • New strategy from the Novartis Foundation to accelerate elimination is focused on interrupting transmission of the disease

  • Last year Novartis renewed its commitment with the WHO to donate multidrug therapy to treat leprosy through the year 2020

  • More than 200,000 people are diagnosed with leprosy every year; approximately 10% of those are children, indicating continued spread of the disease

Novartis Continues Commitment to go the Last Mile in Effort to Eliminate Leprosy

New five-year commitment includes donation of treatments worth more than USD 40 million and is expected to reach an estimated 1.3 million patients
Summary: 

Novartis continues commitment to go the last mile in effort to eliminate leprosy

  • New five-year commitment includes donation of treatments worth more than USD 40 million and is expected to reach an estimated 1.3 million patients
     
  • Novartis Foundation’s new leprosy contact tracing program now launched in five countries
     
  • The company and foundation have a strong legacy in the fight against leprosy, donating medicines and developing programs to improve care of patients
Press Release

Novartis continues commitment to go the last mile in effort to eliminate leprosy

  • New five-year commitment includes donation of treatments worth more than USD 40 million and is expected to reach an estimated 1.3 million patients
     
  • Novartis Foundation’s new leprosy contact tracing program now launched in five countries
     
  • The company and foundation have a strong legacy in the fight against leprosy, donating medicines and developing programs to improve care of patients

Novartis Foundation Leprosy Elimination Dialogue Event Press Release

Novartis Foundation is convening global health experts at a summit in Brazil to discuss the current state of leprosy treatment & care
Press Release

The Novartis Foundation convenes experts to help finish the last mile in leprosy elimination

Subscribe to leprosy elimination